burns epidemiology forecast

Burns Overview

DelveInsight’s ‘Burns – Epidemiology Forecast – 2034’ report delivers an in-depth understanding of burns, historical and forecasted epidemiology, as well as the trends in the United States, EU4 (Germany, France, Italy, and Spain), and the United Kingdom, and Japan. 

Burns Understanding

A burn is an injury to the skin or other organic tissue primarily caused by heat or due to radiation, radioactivity, electricity, friction, or contact with chemicals, with associated significant morbidity and mortality. Burn damage triggers a complex pathophysiological response in the body. Initially, there is tissue damage characterized by cell death, disruption of the skin barrier, and inflammation. Severe burns can result in a systemic inflammatory response syndrome or even sepsis due to compromised immune function and increased susceptibility to infections. Of great importance is that the injury affects not only physical health but also the patient’s mental health and quality of life. Burn injuries are underappreciated trauma that can affect anyone, anytime and anywhere. 

Geographies Covered

• The United States
• EU4 (Germany, France, Italy, and Spain) and the United Kingdom
• Japan

Study Period: 2021-2034

Burns Diagnosis 

The determination of the severity of a burn depends on the depth of the burn and the width of the area. It is necessary to wait for 24–48 h to determine the exact burn grade, as the depth of the burn may increase due to edema and infection. The depth of the burn varies according to the type of the causative agent, the degree of temperature, and the thickness and vascularity of the affected skin area. Accurate assessment of the severity of a burn injury is paramount because it forms the basis for all subsequent treatment decisions, triage plans, and assessment of medical futility. Whenever possible, decisions about proceeding after diagnosis and screening should incorporate patient preferences and expectations about the quality of life. Optimal assessment of the severity of burn injury must involve a systematic, methodical approach, such as that described in course materials for the Advanced Trauma Life Support (ATLS) by the American College of Surgeons Committee on Trauma, Emergency Management of the Severe Burn (EMSB) by the Australian and New Zealand Burn Association, and Advanced Burn Life Support (ABLS) by the ABA.

Continued in the report…..

Burns Epidemiology Perspective by DelveInsight

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by incident cases of burn patients requiring treatment, gender-specific incident cases of treated burn injuries, etiology-specific incident cases of treated burn injuries, severity-specific incident cases of treated burn injuries, and incident cases of hospitalized burn patients in the 7MM covering the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan from 2021 to 2034.

Burns Detailed Epidemiology Segmentation

• As per DeveInsight analysis, in 2023, the total incident cases of burn injuries were reported to be approximately 5,437,532 cases, out of which nearly 1,883,702 cases required medical treatment in the 7MM. These cases are expected to increase by 2034, driven by a surge in industrial accidents, household mishaps, and natural disasters.
• The number of hospitalized burn cases in the 7MM market is expected to increase at an effective CAGR of 0.54% during the study period, i.e. 2021-2034. The forecast period is expected to see a rise in these cases, propelled by heightened awareness of the critical need for timely and suitable treatment of burn injuries, which in turn motivates patients to seek medical care for such cases.
• In 2023, the US had the highest incident population of burn injuries that required medical treatment with nearly 671,128 cases followed by Japan with approximately 329,241 cases and the UK with 280,817 cases. 
• Among the EU4 and the UK, the UK had the highest incident population of burn patients that require medical treatment accounting for approximately 280,817 cases, followed by France and Spain with nearly 204,506, and 145,510 cases respectively. 
• According to DeveInsight analysis in the EU4 and the UK, the majority of burn injury cases taking treatment were males with approximately 540,480 cases and 341,627 female cases in 2023. This is accompanied by the fact that major burn injuries occur at workplaces due to various occupational hazards and exposures. 
• Based on etiology-specific burn incident cases in the US, flame/fire was the foremost contributing cause for burn injuries accounting for approximately 41%, while chemical contact occupied the least share with nearly 3.5% in 2023. Anticipated increases in such cases are attributed to activities such as cooking, motor vehicle incidents, and outdoor pursuits like camping or bonfires.
• In 2023, the severity-specific incident cases were approximately 11,483; 759,667; 79,500; and 32,683 for first-degree, second-degree, third-degree, and unspecified, respectively in the EU4 and the UK. 
• Japan accounted for nearly 17.5% of incident cases of burn injuries requiring medical treatment in 2023. Whereas, the severity-specific incident cases were approximately 71,774; 192,277; 7,243; and 57,946 for first-degree, second-degree, third-degree, and unspecified, respectively in 2023. The forecast period is likely to witness an increase in such cases, driven by Japan's aging population, which is more susceptible to accidents at home, such as burns from cooking or scalding water.

Scope of the Report

• The report covers a descriptive overview of burns, explaining its symptoms, pathophysiology, and various diagnostic approaches.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU4 (Germany, France, Italy, and Spain) the United Kingdom, and Japan.
• The report assesses the disease risk and burden of burns.
• The report helps recognize the growth opportunities in the 7MM concerning the patient population.
• The report provides the segmentation of the disease epidemiology for the 7MM, by incident cases of burn patients requiring treatment, gender-specific incident cases of treated burn injuries, etiology-specific incident cases of treated burn injuries, severity-specific incident cases of treated burn injuries, and incident cases of hospitalized burn patients.

Report Highlights

• 11 years forecast of burns
• The 7MM Coverage
• Incident cases of burn patients requiring treatment
• Gender-specific incident cases of treated burn injuries
• Etiology-specific incident cases of treated burn injuries
• Severity-specific incident cases of treated burn injuries
• Incident cases of hospitalized burn patients.

Key Questions Answered

• What are the disease risks and burdens of burns?
• What is the historical burns patient pool in the United States, EU4 (Germany, France, Italy, and Spain) the United Kingdom, and Japan?
• What would be the forecasted patient pool of burns at the 7MM level?
• What growth opportunities will be across the 7MM concerning the patient population with burns?
• Which country would have the highest incidence of burns among the countries mentioned above during the forecast period (2024–2034)?
• At what CAGR is the population expected to grow across the 7MM forecast period (2024–2034)?

Reasons to Buy

The burns report will allow the user to:

• Develop business strategies by understanding the trends shaping and driving the 7MM burns epidemiology forecast.
• The burns epidemiology report and model were written and developed by Masters and PhD level epidemiologists.
• The burns epidemiology model developed by DelveInsight is easy to navigate, interactive with a dashboard, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports the data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments

• Patient Segmentation
• Disease Risk and Burden
• Risk of Disease by Segmentation 
• Factors Driving Growth in a Specific Patient Population